The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000488.4(SERPINC1):c.1247dup (p.Ser417fs)

CA2580061383

1687103 (ClinVar)

Gene: SERPINC1
Condition: antithrombin III deficiency
Inheritance Mode: Autosomal dominant inheritance
UUID: a03cb4d3-50d8-442c-943f-c2eb6bff0f84
Approved on: 2024-12-20
Published on: 2024-12-20

HGVS expressions

NM_000488.4:c.1247dup
NM_000488.4(SERPINC1):c.1247dup (p.Ser417fs)
NC_000001.11:g.173904037dup
CM000663.2:g.173904037dup
NC_000001.10:g.173873175dup
CM000663.1:g.173873175dup
NC_000001.9:g.172139798dup
NG_012462.1:g.18342dup
ENST00000367698.4:c.1247dup
ENST00000367698.3:c.1247dup
ENST00000617423.4:c.632dup
NM_000488.3:c.1247dup
NM_001365052.1:c.1103dup
NM_001365052.2:c.1103dup
NM_001386302.1:c.1370dup
NM_001386303.1:c.1328dup
NM_001386304.1:c.1226dup
NM_001386305.1:c.1190dup
NM_001386306.1:c.1031dup
More

Uncertain Significance

Met criteria codes 4
PS4_Supporting PVS1_Moderate PM2_Supporting PS3_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Thrombosis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for SERPINC1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Thrombosis VCEP
The c.1247dup (p.Ser417LysfsTer?) variant in SERPINC1 is a frameshift variant that may cause loss of function of the protein, however it is predicted to escape nonsense mediated decay and remove <10% of the protein (PVS1_Moderate). This variant has been reported in at least one family meeting an antithrombin activity level of < 0.8 IU/mL and a family history of the disease with reported antithrombin levels (PS4_Supporting; PMID: 38347553). More affected individuals without the details required for scoring were reported in ClinVar (SCV002520629.1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria to be classified as uncertain significance due to insufficient evidence for autosomal dominant hereditary antithrombin deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Thrombosis VCEP: PVS1_moderate, PM2_supporting, PS4_supporting.
Met criteria codes
PS4_Supporting
This variant has been reported in at least one family meeting an antithrombin activity level of < 0.8 IU/mL and a family history of the disease with reported antithrombin levels (PS4_Supporting; PMID: 38347553). More affected individuals without the details required for scoring were reported in ClinVar (SCV002520629.1).
PVS1_Moderate
The c.1247dup (p.Ser417LysfsTer?) variant in SERPINC1 is a frameshift variant that may cause loss of function of the protein, however it is predicted to escape nonsense mediated decay and remove <10% of the protein (PVS1_Moderate).
PM2_Supporting
This variant is absent from gnomAD v4.1.0 (PM2_Supporting).
PS3_Supporting
Secretion defect demonstrated in PMIDs 36214221, 38347553. Variant activity cannot be measured because the protein is not secreted.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.